Nevertheless, it has been demonstrated that activating mutations of the FLT3 receptor tyrosine kinase are common in acute myelogenous leukemia (AML) and they are found in approximately 5–15% of children and 25–35% of adults with AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.